NCT07182721
- Conditions
- Breast Diseases, Breast Neoplasms, HER2-positive, Unresectable, Locally Advanced or Metastatic Breast Cancer, +6 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, China
Clinical trial condition
Inetetamab
Explore clinical trials studying Inetetamab. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study